Stocks and Investing Stocks and Investing
Wed, April 29, 2020
Tue, April 28, 2020

Charles Duncan Maintained (AXSM) at Buy with Increased Target to $131 on, Apr 28th, 2020


Published on 2024-10-27 04:20:39 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $125 to $131 on, Apr 28th, 2020.

Charles has made no other calls on AXSM in the last 4 months.



There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Joseph Thome of "Cowen & Co." Initiated at Buy and Held Target at $95 on, Tuesday, April 14th, 2020
Contributing Sources